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Background: Hemodialysis access is one of the most common vascular procedures that is performed by vascular and
general surgeons. Prosthetic arteriovenous graft (AVG) infections pose potentially life-threatening septic and bleeding
complications, as well as loss of dialysis access. Strategies employed to preserve some grafts, prevent morbidity in those
with major infections, and maintain access are presented.
Methods: Between July 1, 1995 and August 1, 2002, 1441 AVG procedures were performed at a single institution.
Fifty-one (3.5%) prosthetic AVG infections in 45 patients were identified. Twenty-seven graft infections occurred at a
prior incision for placement or revision of a graft. The other 24 infections were located within the body of the graft, and
14 of these were documented to be at a recent puncture site for hemodialysis access. The most common presentation (47%
[24/51]) was an exposed graft or a draining sinus tract. Management included total graft excision (TGE) when patients
presented with sepsis or the entire graft was bathed in pus; subtotal graft excision (SGE), when all of the graft was
removed except an oversewn small cuff of prosthetic material on an underlying patent artery; and partial graft excision
(PGE), when only a limited infected portion of the graft was removed and a new graft was rerouted through adjacent
sterile tissue to maintain patency of the original graft.
Results: None of the 45 patients died or developed hand ischemia. A uniformly successful outcome was achieved in all
patients who were treated with TGE (13/13: 8 vein patches, 4 primary closure, 1 arterial ligation) or SGE (15/15).
However, these treatments necessitated placement of a central venous catheter for temporary dialysis access and a new
AVG later. All of these 28 wounds healed by secondary intention, including all 15 cases in which an oversewn cuff of
prosthetic material remained. Graft patency and wound healing were achieved in 74% (17/23) of infections treated with
PGE, and placement of a temporary dialysis access catheter and new AVG were avoided. The 6 failures of PGE ultimately
required TGE because of nonhealing wounds, but there were no acute hemorrhagic or septic events.
Conclusions: Systemic sepsis caused by prosthetic AVG infections mandates TGE. SGE and PGE can be safely employed
in selected patients with infected prosthetic AVGs. SGE maintains patency of the underlying artery and avoids a difficult
and time-consuming dissection. PGE offers the advantage of minimizing extensive dissection of well-incorporated
uninfected graft segments and allows continued dialysis access at the incorporated portion of the graft. (J Vasc Surg
2004;39:73-8.)
Dialysis access is one of the most common procedures
performed by vascular and general surgeons in the United
States. It is estimated that more than 250,000 persons in
the United States currently require hemodialysis.1 Access-
related morbidity represents a significant problem in the
care of these patients. Infection of PTFE grafts is second
only to thrombosis as a complication of graft placement. It
is estimated that 20% to 36% of all deaths in the dialysis
population occur as a result of infectious complications,
although the mortality rate specifically for infected pros-
thetic hemodialysis grafts is much lower.2 The cost to our
health care system is considerable and is estimated to ex-
ceed $1 billion per year, with17% of this spent toward the
care of access-related morbidity.3 It is difficult to determine
the exact cost that is attributable specifically to infected
prosthetic hemodialysis grafts, but it is considerable, con-
sidering the need for prolonged length of hospital stay,
repeated operations, antibiotics, and other factors in pa-
tients who suffer these complications.
Of all potential access morbidity, prosthetic vascular
graft infection may be the most challenging and life threat-
ening. The patient is at risk for life-threatening sepsis or
hemorrhage and often must endure multiple procedures to
manage the problem. Historically, this has mandated com-
plete graft removal, a large open wound, and placement of
temporary central venous access.1,4,5 Although excision of
infected prosthetic hemodialysis grafts frequently can be
accomplished with shorter incisions and skin bridges, with
closure of some wounds over drains, the operation can
still be extensive and difficult. Once the infection is re-
solved, new permanent access is obtained at a separate
site, and temporary access is removed once the new
permanent access matures and is functional. Given the
limited number of peripheral access sites, partial salvage of
grafts represents an appealing option in this difficult group
of patients.6 We review our experience with prosthetic
hemodialysis graft infection and present our results specif-
ically addressing selective use of graft preservation tech-
niques.
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PATIENTS AND METHODS
Between July 1, 1995 and August 1, 2002, 1441
prosthetic AVG procedures were performed at Pennsylva-
nia Hospital. Fifty-one (3.5%) prosthetic (polytetrafluoro-
ethylene [PTFE] ) AVG infections in 45 patients were
identified. This figure represents the lowest possible inci-
dence of prosthetic AVG infections at our hospital; the
actual rate may be higher, because some patients were
followed at other dialysis centers or moved out of our area.
Therefore, follow-up of all patients with prosthetic AVGs
was not complete. Data collected included graft location,
number of revisions before infection, interval period be-
tween intervention and infection, and location of the infec-
tion on the graft. Graft location was categorized according
to the recommended standards for reports dealing with
arteriovenous access.7 Infection location was defined as
occurring at a recent incision or within the body of the
graft, with or without a recent dialysis puncture site. Clin-
ical presentation was categorized as systemic sepsis, a drain-
ing sinus tract, exposed graft, purulent drainage, erythema,
pain overlying the graft, hemorrhage, or a combination of
the above (ie, weakened graft with a number of puncture
holes with hemorrhage, false aneurysm with skin erosion
resulting in graft exposure or hemorrhage). In a few cases,
unexpected purulence was encountered during a throm-
bectomy or revision in an otherwise symptom-free patient.
Stat Gram stains and wound cultures were routinely sent
from the operating room. These grafts were treated as
infected grafts either because the Gram stains or cultures
returned as positive for bacteria or because grossly purulent
fluid was found. None of these grafts had been recently
placed, and they were removed solely on the basis of poor
incorporation. All patients who were admitted to the hos-
pital for graft infections were started on broad-spectrum
antibiotics, typically vancomycin and gentamycin. Once
culture and sensitivity results were obtained, more specific
antibiotics were administered for appropriate coverage. In
most cases, the nephrologists dosed the antibiotics at each
Management of suspected prosthetic arteriovenous graft infections.
JOURNAL OF VASCULAR SURGERY
January 200474 Ryan et al
dialysis session for a period of 6 weeks after surgical treat-
ment.
Surgical management of dialysis graft infections in-
cluded the following strategies. First, total graft excision
(TGE) was undertaken when infection was responsible for
systemic sepsis or hemorrhage at the anastomosis. The
entire graft was removed, and the arterial defect was
patched with autologous vein or primarily repaired. Rarely,
the underlying thrombosed or diseased artery was ligated.
Involved veins were routinely ligated or oversewn. The
wounds were left open to heal by secondary intention, or a
drain was placed within the subcutaneous tunnel if the graft
could be removed through multiple short incisions. TGE
mandated placement of a temporary dialysis catheter. Days
or weeks after the patient recovered from the septic epi-
sode, placement of a new AVG was carried out at another
location. Ultimately, the temporary venous catheter was
removed.
When a patient presented with an infected prosthetic
dialysis graft but without sepsis (stable hemodynamic pa-
rameters, a mildly elevated or normal white blood cell
count, low grade or absent fever), graft preservation tech-
niques were considered.
Subtotal graft excision (SGE) was defined as removal of
all of the graft with the exception of an oversewn cuff of
prosthetic material on an underlying patent artery.8-10 Sim-
ilar to our experience with infected peripheral bypass grafts,
this strategy was employed if the arterial anastomosis was
intact and encased in scar tissue.8 By oversewing a 2- to
3-mm cuff of the original prosthetic graft on the underlying
artery after excising the remainder of the graft, we avoided
the need for placing an autogenous patch and dissecting an
artery encased in scar tissue. This strategy preserved patency
of the underlying artery and minimized the risk of nerve
damage and bleeding during a hazardous dissection. Ag-
gressive debridement of the wound and frequent dressing
changes were mandatory for promoting granulation tissue
to incorporate the oversewn prosthetic patch and ensure
successful wound healing.
Partial graft excision (PGE) was employed if the infec-
tion was localized to one segment of the graft and a
preoperative ultrasound was negative for the presence of
fluid around the remaining uninfected portions of the graft.
After preparing the arm, the area of exposed graft or
isolated infection was covered with occlusive dressings.
Segments of sterile graft that were proximal and distal to
the infected area were dissected free. If these segments were
not well incorporated, then the strategy was abandoned,
and TGE or SGE excision was performed. If the adjacent
segments were well incorporated, new graft was tunneled in
adjacent sterile tissue and anastomosed to the proximal and
distal uninfected portions of the graft. The sterile end of the
intervening infected graft segment was partially resected
toward the area of infection and was ligated to allow closure
of the tunnel with a purse-string subcutaneous suture, with
care taken not to violate the area of isolated infection within
the tunnel. Once the new graft was placed, the wounds
were closed, and sterile dressings were applied. Next, the
infected portion of the graft was removed through the
infected wound without violating the previous sterile inci-
sions. The main advantages of PGE were that incorporated
portions of the graft were available for immediate dialysis,
temporary venous access was not required, and the location
of the graft was maintained.
RESULTS
Mean age of these 45 patients with 51 prosthetic AVG
infections was 58.3 years (range, 42 to 78 years). About half
(23/45, 51%) of the patients had diabetes mellitus. Thirty-
two (62.8%) grafts were prosthetic brachial-antecubital
forearm loop–access grafts, 4 (7.8%) were prosthetic radial-
antecubital forearm straight-access grafts, and 15 (29.4%)
were prosthetic brachial-brachial upper arm loop–access
grafts.
The most common presentations of prosthetic AVG
infection in this series were an exposed graft or a draining
sinus tract (23/51, 45.1%; Table 1). Overt sepsis was
relatively uncommon, occurring in only 5 patients (9.8%)
and without other signs of infection. The graft was found to
be the source of sepsis, on the basis of duplex ultrasonog-
raphy showing fluid around the graft, which was confirmed
by graft exploration and excision and absence of any other
foci of sepsis such as pneumonia. In patients who presented
with erythema or hematoma, wound or fluid cultures were
positive, or fluid suspicious of infection was found during
surgical exploration. In one case, pain overlying the graft
was the only manifestation of infection.
Twenty-seven graft infections (53.0%) occurred at a
prior incision for placement or revision of a graft. These
initial or re-do incisions were all closed with a running
subcuticular absorbable suture, and retractors were not
placed during graft thrombectomy. Instead, angled clamps
were applied across each end of the graft that was exposed
in the wound, and these clamps functioned as retractors to
expose the graftotomy. The other 24 infections (47.0%)
were located within the body of the graft where the graft
had been tunneled but where there were not any prior
incisions, and 14 (27.4%) of these were documented to be
at a recent puncture site for hemodialysis access. Twenty-
four infections (47.0%) presented within 1 month of a
revision or placement, 20 (39.3%) presented within 2 to 6
months, and 7 (13.7%) presented more than 6 months after
surgical revision or placement. The majority of the infec-
Table I. Presentations of 51 PTFE AVG infections
Presentation n
Exposed graft/sinus tract 23
Purulent drainage 6
Sepsis 5
Unexpected purulence 5
Erythema 4
Hemorrhage 4
Hematoma 3
Pain 1
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tions that presented within a month of a recent revision
(18/24, 75.0%) were associated with the incision, and the
majority of the infections that presented more than 1
month after surgery (21/27, 77.7%) were in the body of
the graft where the graft had been tunneled under the skin
and where a prior incision had not been made.
There were no deaths in this series as a result of a graft
infection. There were no clinically apparent ischemic hand
complications or episodes of life-threatening hemorrhage
during long-term follow-up (0.5 to 48 months; mean, 9.6
months; median, 8.1 months; 39% followed for 1 year).
Thirteen patients were treated with TGE. As men-
tioned previously, duplex ultrasound examination of the
graft revealed fluid around the graft in a few systemically
septic patients without other clinical signs of infection,
which prompted TGE. When patients demonstrated criti-
cal sepsis, we believed that TGE was necessary so that there
was not any graft remnant to serve as a potential source of
infection. If we believed that patients were not truly septic,
then SGE was performed. A successful outcome was
achieved in all patients who were treated by TGE in that all
wounds healed and patients survived. Eight patients under-
went vein-patch closure of the arteriotomy, 4 underwent
primary arterial closure because of sufficient arterial caliber,
and 1 underwent ligation of a thrombosed radial artery.
In 15 patients, SGE was performed. In these patients,
the infection involved the majority of the graft, precluding
PGE, but the area of the arterial anastomosis remained well
incorporated by dense scar tissue where sharp dissection
proved very difficult. A small oversewn cuff of prosthetic
tissue was left on the arterial anastomosis. In all 15 cases,
the wounds healed by secondary intention entirely or,
rarely, by muscle mobilization to cover the prosthetic cuff
(when possible) without sequelae, and remained healed
without evidence of hemorrhage or recurrent infection
during follow-up.
In almost half (23/51, 45.1%) of infected prosthetic
grafts in this series, PGE was attempted. Preservation of a
significant part of the incorporated graft was possible,
thereby enabling these patients to be dialyzed immediately,
without the need for a central catheter. Ultimately, six
patients required TGE because of nonhealing wounds, for
an overall success rate of 74% (17/23). The location of the
initial infection did not appear to be predictive of success of
partial excision, but the number of cases was small (Table
II). There were no episodes of life-threatening hemorrhage
or sepsis when a strategy of PGE was attempted, including
unsuccessful cases.
Purulent fluid was encountered in five patients (9.8%)
without clinical evidence of a graft infection during a
planned thrombectomy. One of these patients had the
entire graft removed, and four of these patients were
treated with either subtotal (2) or partial (2) graft excision.
Both of the PGE cases healed without complication.
Bacterial cultures were positive in 38 (75%) cases and
negative in 13 (25%) cases, despite fluid or pus surrounding
the graft and with other manifestations of infection such as
erythema, a draining sinus tract, or sepsis. This high inci-
dence of negative cultures was due to problems in retriev-
ing bacterial culture results from the hospital microbiology
laboratory because of frequent changes in data computer
storage and was also due to the fact that many patients were
started on intravenous antibiotics before cultures were
taken in the operating room. Of the 38 culture-positive
wounds, the most common organism was Staphylococcus
aureus (23; 60%), with Staphylococcus epidermidis (15),
Streptococcus viridans (11), Streptococcus faecalis (10),
Pseudomonas aeruginosa (8), and Zanthoma maltophilia
(1) also cultured (many cultures were polymicrobial). Cor-
relation of bacterial cultures with success of treatment
applied only to patients who were treated by PGE, because
the wounds of patients who were initially treated by TGE or
SGE healed without any complications. TGE was ulti-
mately required after failure of PGE in 6 cases; Staphylococ-
cus aureus was cultured from these wounds in five cases and
S viridans in one case. Because of these small numbers of
failures, it is difficult to determine whether a certain type of
bacteria was more likely associated with success or failure of
any strategy.
DISCUSSION
Dialysis prosthetic graft infection has been treated by
total graft removal at some centers, regardless of presenta-
tion. When patients presented to us with evidence of sys-
temic sepsis, heralded by fever, leukocytosis, or hypoten-
sion, TGE was performed. This strategy was successful in
the 13 patients we treated, in that wounds ultimately healed
and patients survived, but with significant morbidity. This
strategy mandated placement of temporary hemodialysis
access; removal of the graft with the potential risk of
bleeding, ischemia, or nerve injury; and loss of that site for
future permanent grafts. Most of these patients were left
with large open wounds to heal by secondary intention.
The morbidity associated with this strategy and the rela-
tively infrequent presentation of overt sepsis prompted us
to attempt graft salvage techniques in selected patients.
When most of the graft was infected, but the arterial
anastomosis remained well incorporated, leaving a small
cuff of PTFE on the artery simplified treatment, reducing
the risk of nerve injury and hemorrhage. For peripheral
bypass grafts, we have described leaving an oversewn cuff of
prosthetic graft on the femoral artery when removing in-
fected bypass grafts, with success rates of 90%.8-11 Simi-
larly, Gifford et al12 removed grafts in 15 hemodialysis
patients, leaving a prosthetic cuff on the arterial anastomo-
sis. Fourteen of 15 healed without sequelae. One patient
Table II. Partial graft excision: location versus success
Location of infection n Successful outcome (n)
Incision 12 9
Body 4 4
Body with puncture site 7 4
Total 23 17 (74%)
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developed a pseudoaneurysm, which was treated without
further complication. However, there is not consensus on
this strategy, and other surgeons do not generally recom-
mend this approach. Investigators at the University of
Miami recommended removal of all graft material after they
found that 17% of the infections in their series were the
result of infected cuffs.13 The overall failure rate of all
patients who were treated with SGE in their series was not
mentioned, but possibly those investigators oversewed an
infected prosthetic cuff of a poorly incorporated graft rem-
nant. In our series, a cuff was left only if the anastomosis was
well incorporated. Postoperative wound debridements
were carried out as necessary, and wet-to-dry dressing
changes were performed at least twice daily. With this
technique, all patients healed without evidence of contin-
ued infection. We did not favor closing the wounds over
suction drains for fear of recurrent infection. We believe
that this technique, when used appropriately, is safe, re-
duces potential morbidity, and simplifies graft excision.
Graft preservation techniques, first introduced by Bhat
et al6 at Montefiore Medical Center, remain controversial
but may be ideally suited in the hemodialysis population, in
which localized infection often occurs. A strategy of PGE
relies on the presence of localized infection and a good
portion of remaining incorporated graft for bypass. A seg-
mental bypass technique, similar to our proposed PGE
technique, was employed by Raju14 at the University of
Mississippi in 44 patients, with only 5 failures. Similar to
our findings, Taylor et al15 reported an 80% success rate
with the use of segmental bypass that was attempted in 60%
of patients who presented with an infected AVG. Palder et
al16 successfully employed segmental bypass in 22 selected
patients who had localized AVG infection. It is noteworthy
that failure of this strategy in our series was not associated
with life-threatening complications, such as bleeding or
sepsis. Furthermore, the incorporated portions of the graft
were available for immediate hemodialysis and thus obvi-
ated the need for temporary venous access.
These techniques require careful patient selection and,
at times, willingness to abandon the technique if extensive
infection is found at the time of operation. We propose an
algorithm for the treatment of a suspected prosthetic fistula
infection (Fig). If clinically apparent sepsis is present, her-
alded by high fevers, leukocytosis, or hypotension, the
infected graft should be immediately and completely re-
moved. If the infection is localized by clinical examination
and a preoperative ultrasound is negative for the presence
of more extensive infection, PGE can be attempted. Al-
though occasionally preoperative ultrasound will not detect
fluid around an infected graft, a positive finding almost
always correlates with infection. We frequently have diag-
nosed patients who do not have clinical evidence of graft
infection but in whom ultrasound has confirmed the pres-
ence of fluid and infection has been documented. If in the
operating room the graft is not well incorporated or the
entire graft is infected, then an SGE (well-incorporated
anastomosis) or TGE should be performed.
Almost half of the infections in this series were from a
recent incision (24/51, 47%), whereas the remainder pre-
sented within the body of the graft, not at a recent incision
(27/51, 53.0%). A significant number of graft infections
arose at the site of a previous incision for graft thrombec-
tomy and revision, probably for the same reasons that re-do
wound explorations in other areas of the body, namely scar
tissue resulting in relatively ischemia and poorer wound
healing. Preventing these complications may potentially be
avoided by careful dissection and meticulous wound clo-
sure, but the best method is to perform graft revisions
through virginal skin and subcutaneous tissue. The major-
ity of infections (21/27, 77.7%) that occurred more than 1
month after surgery were not associated with an incision.
Similarly, Schild et al13 found that 50% of the infections in
their series were attributable to routine dialysis, which they
defined as infections that occurred more than 1 month after
surgery. Although the development of AVG infection is
clearly multifactorial, our data emphasize the need for strict
attention to sterile technique not only by surgeons and
interventional radiologists but especially by dialysis nurses
when performing AVG needle insertions. Overlying skin
can erode after multiple needle punctures and can lead to
graft exposure and infection. Clearly dialysis nurses need to
avoid these areas of skin breakdown when performing
future needle punctures of the graft.
In addition to a functioning AVG, it is not uncommon
for dialysis patients to have thrombosed, abandoned dialy-
sis grafts. Typically, it is not necessary to remove throm-
bosed grafts once the decision is made to abandon them, so
long as they remain uninfected. In our series, four patients
had infections in thrombosed, abandoned grafts, all of
which were apparent on physical examination. It is clear
from this study and others that abandoned grafts continue
to pose an infectious risk and may not often be apparent by
physical examination. In a series of 87 patients from the
University of Miami, infections involving 30 abandoned
grafts were found.13 Nassar and Ayus1 reported 20 patients
with infected thrombosed, abandoned PTFE grafts who
presented with fevers only (15) or with sepsis (5) and in
whom the source of infection was not clearly associated
with the abandoned AVG. Blood cultures in 15 of 20
patients were positive. Indium scans were positive in all 20
patients, and purulent material was found surrounding the
grafts in all cases. A comparison was performed with 21
symptom-free patients with abandoned, thrombosed PTFE
grafts, and 15 were found to have positive indium scans.
Subsequent removal of the AVG in these patients revealed
purulence surrounding the graft in 13 of 15 patients. These
studies emphasize the importance of maintaining a high
clinical suspicion for infection in abandoned, thrombosed
grafts.
Hemodialysis graft infection management requires a
balance to achieve eradication of infection and continued
means to achieve hemodialysis with reduced overall mor-
bidity. In carefully selected patients with an infected hemo-
dialysis AVG infection, PGE and STE represent an im-
proved strategy that can be expected to achieve a high
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likelihood of success with minimal morbidity and with
greater salvage of involved grafts.
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DISCUSSION
Dr David K. W. Chew (West Roxbury, Mass). As recently as
one month ago we had a patient who had an infected dialysis graft;
the proximal anastomosis was very densely incorporated, and so
the surgeon left a cuff of the graft and did a subtotal excision. The
patient promptly blew out 2 weeks later from that stump of
prosthetic graft that was left behind. I think it had to do with the
virulence of the infection, which was gram-negative Klebsiella. I
was wondering whether you have any data on the type of bacteria
in your series—whether there is any influence on the safety of the
management that you adopted.
Dr Sean Ryan. That’s a good question. The majority of our
cultures were staph species. We also had some Pseudomonas, Strep-
tococcus viridans, and Enterococcus. In a large portion of our patients,
about 25%, the cultures were negative. There is no way for us to
predict success on the basis of microbiology because the subgroups of
patients were treated in different ways and that dilutes any analysis. I
think that certain bacteria, such as Pseudomonas, based on other
studies we and others have published, are more worrisome.
Dr Peter J. Pappas (Newark, NJ). I want to congratulate you
on tackling a very difficult group of patients. Your data indicates
that you do approximately 200 prosthetic grafts a year. At our
institution we’ve found that the best way to avoid a prosthetic graft
complication is to minimize the use of prosthetic grafts for dialysis
access and maximize the use of autogenous fistulae. I would
therefore like to ask how many autogenous arteriovenous fistulae
were performed at your institution during the same time period.
The second question is, of those patients who required a total
graft excision, did you place another prosthetic graft or did you
look to see if the patient had an autogenous option for access? We
have found that over 50% of our patients who had a prosthetic graft
that failed or had to be removed were candidates for a fistula, if you
investigate their extremity veins, utilizing duplex ultrasonography.
Dr Ryan. We have a strategy at Pennsylvania Hospital where
we perform autogenous primary fistulae whenever possible. We
routinely perform preoperative duplex scan vein mapping of both
upper extremities.
Dr Paul J. Gagne (New York, NY). I congratulate you on your
careful analysis. My question is, you describe using subtotal graft
excision to avoid complications related to total graft excision. In the
patients in whom you performed total graft excision, did you see the
complications that you were trying to avoid with subtotal graft exci-
sion?
And the second part of my question is, a number of the
patients who had partial graft excision went on to total graft
excision. Did they have complications that could have been
avoided if you had done a subtotal excision to begin with?
Dr Ryan. Almost all patients treated by total graft excision did
well and indeed did not suffer the complications we were trying to
avoid by selectively using subtotal graft excision. But remember
that the patients treated by total graft excision often had poorly
incorporated grafts at the anastomosis. Therefore, the dissection
was easier and inadvertent injury to the adjacent veins and nerves
was less likely than if the graft was well incorporated, which were
the situations in which we employed subtotal graft excision. The
six patients who ultimately required total graft excision after failing
partial graft excision also did well.
Dr Dean J. Wickel (San Antonio, Tex). I have a question
about how you and Dr. Calligaro handle patients who are admitted
by the nephrologist for bacteremia, maybe not overtly septic. You
do a CT scan or an ultrasound, you don’t find any obvious fluid
around the graft, and then they order that tagged white cell study
which lights up a little something around your graft. How do you
handle those patients?
Dr Ryan. It really depends on the clinical situation. We agree
that you must aggressively look for other sources of infection. If none
are found and you have a positive white cell scan, the study is very
sensitive for the presence of infection. So I think that you should treat
those aggressively in the absence of any other source of infection.
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